Capsaicin to Control Pain Following Third Molar Extraction
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00088686 |
Recruitment Status :
Completed
First Posted : August 2, 2004
Last Update Posted : March 4, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Capsaicin to Control Pain Following Third Molar Extraction
Summary: This study will test the effectiveness of the drug capsaicin in controlling pain after third molar (wisdom tooth) extraction. Capsaicin, the ingredient in chili peppers that makes them "hot," belongs to a class of drugs called vanilloids, which have been found to temporarily inactivate pain-sensing nerves. If capsaicin alleviates pain in dental surgery, it may have potential for use in many types of surgery and painful illnesses.
Healthy normal volunteers between 16 and 40 years of age who require third molar (wisdom tooth) extraction may be eligible for this study. Participants undergo the following procedures in three visits:
Visit 1
Patients have touch (sensory) testing inside the mouth using three methods: 1) applying a temperature probe onto the gums and having the patient rate how warm it is; 2) applying a gentle stroke across the gums with the bristles of a small paint brush and having the patient say whether or not it feels painful; and 3) applying a light touch to the gums with a small needle and having the patient rate the pain intensity following the touch. Following touch testing, the patient's mouth is numbed with an anesthetic and a small piece of gum tissue next to the lower wisdom tooth is removed (biopsied). Then, a small amount of either capsaicin or placebo (saline, or salt water) is injected next to the wisdom tooth.
Visit 2
Following repeat the touch testing, patients are sedated with an injection of midazolam. They then have another biopsy under local anesthesia on the same side of the mouth as the first biopsy. Their mouth is again numbed with an anesthetic, and they are given either a pain-relieving medicine called Toradol or a placebo injected into the arm. One lower wisdom tooth is then extracted. After the extraction, pain ratings are recorded every 20 minutes for up to 6 hours. During this time, patients are monitored for vital signs, numbness, pain, and side effects. Patients who request pain-relief medication are given acetaminophen and codeine. At the end of the study, they are discharged from the clinic and given acetaminophen and codeine to take at home, as instructed. They are provided a pain diary to record pain ratings and any adverse reactions that might occur until the last visit.
Visit 3
Patients return for a follow-up evaluation 48 hours after discharge from the clinic. At the end of the evaluation, they are discharged home with flurbiprofen for pain relief. Remaining wisdom teeth are removed "off-study" no sooner than 1 week following the first visit.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Healthy Tooth Extraction | Drug: Capsaicin (Intramucosal Injection) | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 75 participants |
Primary Purpose: | Treatment |
Official Title: | Evaluation of Vanilloid Receptor Inactivation for Preemptive Analgesia |
Study Start Date : | July 2004 |
Study Completion Date : | October 2005 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
INCLUSION CRITERIA:
Male or female volunteers referred for mandibular third molar extraction with a minimal difficulty rating score of 2 - 3 at the time of screening; rating will be verified by the oral surgeon at time of surgery. (Rating scale: 1 = erupted; 2 = soft tissue impaction; 3 = partial bony impaction; 4 = full bony impaction).
Age between 16-40.
ASA status 1 or 2, deemed in good general health (able to tolerate outpatient conscious sedation safely).
Willing to wait up to 4 hours for post-operative observation.
Willing to return at 48 hours for a second tissue biopsy.
EXCLUSION CRITERIA:
ASA status 3-5 and Emergency operation (E) that do not get a physician clearance; i.e. systemic disturbances that limits the patient's activity.
Pregnant or breast-feeding mothers.
Allergy to investigational drugs or to red chili peppers.
Chronic use of analgesics (not limited to, but including: non-steroidal anti-inflammatory medications, steroids, anti-depressants, anti-convulsants).
Presence of chronic disease (e.g. cardiovascular disease, liver disease, kidney disease, diabetes, etc.).
No exclusions will be made based on race, gender, or religion.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00088686
United States, Maryland | |
National Institute of Dental And Craniofacial Research (NIDCR) | |
Bethesda, Maryland, United States, 20892 |
ClinicalTrials.gov Identifier: | NCT00088686 |
Other Study ID Numbers: |
040248 04-D-0248 |
First Posted: | August 2, 2004 Key Record Dates |
Last Update Posted: | March 4, 2008 |
Last Verified: | October 2005 |
Preemptive Analgesia Vanilloid Capsaicin Acute Pain Orofacial |
Vanilloid Receptor (VR) Visual Analog Scale (VAS) Wisdom Teeth Third Molar Extraction |
Capsaicin Antipruritics Dermatologic Agents |
Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs |